Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program

Detalles Bibliográficos
Autores principales: Van Buynder, Paul Gaston, Newbound, Angela, MacIntyre, C. Raina, Kennedy, Alexander Thomas, Clarke, Christopher, Anderson, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828056/
https://www.ncbi.nlm.nih.gov/pubmed/34542384
http://dx.doi.org/10.1080/21645515.2021.1967042
_version_ 1784647779785637888
author Van Buynder, Paul Gaston
Newbound, Angela
MacIntyre, C. Raina
Kennedy, Alexander Thomas
Clarke, Christopher
Anderson, Jonathan
author_facet Van Buynder, Paul Gaston
Newbound, Angela
MacIntyre, C. Raina
Kennedy, Alexander Thomas
Clarke, Christopher
Anderson, Jonathan
author_sort Van Buynder, Paul Gaston
collection PubMed
description
format Online
Article
Text
id pubmed-8828056
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88280562022-02-10 Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program Van Buynder, Paul Gaston Newbound, Angela MacIntyre, C. Raina Kennedy, Alexander Thomas Clarke, Christopher Anderson, Jonathan Hum Vaccin Immunother Commentary Taylor & Francis 2021-09-20 /pmc/articles/PMC8828056/ /pubmed/34542384 http://dx.doi.org/10.1080/21645515.2021.1967042 Text en © 2021 Seqirus. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Commentary
Van Buynder, Paul Gaston
Newbound, Angela
MacIntyre, C. Raina
Kennedy, Alexander Thomas
Clarke, Christopher
Anderson, Jonathan
Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title_full Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title_fullStr Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title_full_unstemmed Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title_short Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
title_sort australian experience of the sh21 flu vaccination program during the covid-19 vaccine program
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828056/
https://www.ncbi.nlm.nih.gov/pubmed/34542384
http://dx.doi.org/10.1080/21645515.2021.1967042
work_keys_str_mv AT vanbuynderpaulgaston australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram
AT newboundangela australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram
AT macintyrecraina australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram
AT kennedyalexanderthomas australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram
AT clarkechristopher australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram
AT andersonjonathan australianexperienceofthesh21fluvaccinationprogramduringthecovid19vaccineprogram

Ejemplares similares